These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417 [TBL] [Abstract][Full Text] [Related]
26. Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm. Marichal-Cancino BA; Sánchez-Fuentes A; Méndez-Díaz M; Ruiz-Contreras AE; Prospéro-García O Behav Pharmacol; 2016 Jun; 27(4):393-6. PubMed ID: 26292188 [TBL] [Abstract][Full Text] [Related]
27. Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats. Patricio F; Morales Dávila E; Patricio-Martínez A; Arana Del Carmen N; Martínez I; Aguilera J; Perez-Aguilar JM; Limón ID Front Pharmacol; 2022; 13():945836. PubMed ID: 36120297 [TBL] [Abstract][Full Text] [Related]
28. Systematic synthesis of novel phosphoglycolipid analogues as potential agonists of GPR55. Abe J; Guy AT; Ding F; Greimel P; Hirabayashi Y; Kamiguchi H; Ito Y Org Biomol Chem; 2020 Nov; 18(41):8467-8473. PubMed ID: 33063071 [TBL] [Abstract][Full Text] [Related]
29. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans. Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953 [TBL] [Abstract][Full Text] [Related]
30. Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats. Rahimi A; Hajizadeh Moghaddam A; Roohbakhsh A Fundam Clin Pharmacol; 2015 Apr; 29(2):185-90. PubMed ID: 25620584 [TBL] [Abstract][Full Text] [Related]
31. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors. Anavi-Goffer S; Irving AJ; Ross RA J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417 [TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells. Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382 [TBL] [Abstract][Full Text] [Related]
33. The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55. Kargl J; Balenga NA; Platzer W; Martini L; Whistler JL; Waldhoer M Br J Pharmacol; 2012 Apr; 165(8):2611-9. PubMed ID: 21718301 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of GPR55, a putative cannabinoid receptor. Sharir H; Abood ME Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715 [TBL] [Abstract][Full Text] [Related]
35. GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier. Leo LM; Familusi B; Hoang M; Smith R; Lindenau K; Sporici KT; Brailoiu E; Abood ME; Brailoiu GC Neuroscience; 2019 Aug; 414():88-98. PubMed ID: 31279825 [TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidylinositol, especially albumin-bound form, induces inflammatory cytokines in macrophages. Kurano M; Kobayashi T; Sakai E; Tsukamoto K; Yatomi Y FASEB J; 2021 Jun; 35(6):e21673. PubMed ID: 34042213 [TBL] [Abstract][Full Text] [Related]
37. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Nevalainen T; Irving AJ Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712 [TBL] [Abstract][Full Text] [Related]
38. Central GPR55 may prevent nicotine reinforcing actions: a preliminary study. Díaz-Barba A; Calvillo-Robledo A; Vázquez-León P; Gallegos-Vieyra E; Quintanar JL; Marichal-Cancino BA Acta Neurobiol Exp (Wars); 2022; 82(3):304-314. PubMed ID: 36214713 [TBL] [Abstract][Full Text] [Related]
39. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55. Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700 [TBL] [Abstract][Full Text] [Related]